“Long-Term Improvements in Health-Related Quality of Life of Patients With Moderate to Severe Plaque Psoriasis Treated With Certolizumab Pegol: Results from the CIMPASI-1 and CIMPASI-2 Phase 3 Trials”. SKIN The Journal of Cutaneous Medicine, vol. 5, no. 1, Jan. 2021, p. s20, https://doi.org/10.25251/skin.5.supp.20.